Open AccessA system approach to intravenous thrombolysis in acute myocardial infarction in community hospitals: The influence of paramedics
Author(s) -
Hartmann J.,
Mckeever L.,
Bufalino V.,
Marek J.,
Brown A.,
Goodwin M.,
Colandrea M.,
Stamato N.,
Cahill J.,
Amirparviz F.
Publication year - 1988
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.4960111203
Subject(s) - medicine , thrombolysis , myocardial infarction , streptokinase , emergency medicine , community hospital , angiography , psychiatry
During a 3‐year period, intravenous streptokinase (IV STK) was given to 110 consecutive patients ages 34–78 in the course of acute myocardial infarction (AMI) in three community hospitals served by the same paramedic system. 1.5 million units of IV STK was given over 30 minutes. Half of the patients were brought to the hospital by paramedics. The average time from onset of pain to administration of IV STK was 107 minutes in the paramedic group and 182 minutes for the others. Of 110 patients, 98 (89%) showed clinical evidence of reperfusion and 94 of 106 patients (89%) showed angiographic reperfusion. Angiography was performed from 1 to 10 days post‐AMI. Mean time to angiography was 6 days for the first 58 patients and 2 days for the last 52 patients. In‐hospital mortality was 2 of 110 patients and there was 1 late death at 8 months for an overall 3‐year mortality 2.7%. Of 86 patients, 83 (96%) working before their infarct are working now. Of 107 survivors, 96 (90%) are Functional Class I. Conclusions: (1) IV STK is safely administered in a high percentage of AMI patients. (2) IV STK is safely administered in community hospitals. (3) Paramedics act as an early warning system and allow for earlier treatment than patients presenting without paramedic involvement. (4) Successful coronary reperfusion with IV STK results in low mortality rates and minimizes functional disability. (5) A systemwide approach to reducing time to treatment in AMI may be the most influential factor in affecting morbidity and mortality.